Kajanti, M <br/><br/>
Intra-arterial and intravenous use of 4' epidoxorubicin combined with 5-fluorouracil in primary hepatocellular carcinoma. A randomized comparison.  [electronic resource] 

 -  American journal of clinical oncology  Feb 1992 
 - 37-40 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0277-3732 
<br/><br/><label>Standard No.: </label>10.1097/00000421-199202000-00008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Carcinoma, Hepatocellular--drug therapy<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Infusions, Intra-Arterial<br/>Infusions, Intravenous<br/>Injections, Intra-Arterial<br/>Injections, Intravenous<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Remission Induction<br/>Survival Analysis